Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kappler

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
International Journal of Hygiene and Environmental Health|June 24, 2005
DNA adduct formation of benzo[a]pyrene in white blood cells of workers exposed to polycyclic aromatic hydrocarbonsThomas Mensing, Boleslaw Marczynski, Beate Engelhardt, et al.
Archives of Toxicology|May 20, 2006
Irritative effects of fumes and aerosols of bitumen on the airways: results of a cross-shift studyMonika Raulf-Heimsoth, Beate Pesch, Klaus Schott, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2006
Assessment of DNA damage in WBCs of workers occupationally exposed to fumes and aerosols of bitumenBoleslaw Marczynski, Monika Raulf-Heimsoth, Ralf Preuss, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Dose-response modeling of occupational exposure to polycyclic aromatic hydrocarbons with biomarkers of exposure and effectBeate Pesch, Martin Kappler, Kurt Straif, et al.
Eclinicalmedicine|November 8, 2024
Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controlled, phase 2 trialMaria Pilar Ruiz Seco, José Ramón Paño Pardo, Christian Schoergenhofer, et al.
International Clinical Psychopharmacology|February 27, 2026
Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressantsClotilde Guidetti, George I Papakostas, Steven Stahl, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Hygiene and Environmental Health|June 24, 2005
DNA adduct formation of benzo[a]pyrene in white blood cells of workers exposed to polycyclic aromatic hydrocarbonsThomas Mensing, Boleslaw Marczynski, Beate Engelhardt, et al.
Archives of Toxicology|May 20, 2006
Irritative effects of fumes and aerosols of bitumen on the airways: results of a cross-shift studyMonika Raulf-Heimsoth, Beate Pesch, Klaus Schott, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2006
Assessment of DNA damage in WBCs of workers occupationally exposed to fumes and aerosols of bitumenBoleslaw Marczynski, Monika Raulf-Heimsoth, Ralf Preuss, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Dose-response modeling of occupational exposure to polycyclic aromatic hydrocarbons with biomarkers of exposure and effectBeate Pesch, Martin Kappler, Kurt Straif, et al.
Eclinicalmedicine|November 8, 2024
Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controlled, phase 2 trialMaria Pilar Ruiz Seco, José Ramón Paño Pardo, Christian Schoergenhofer, et al.
International Clinical Psychopharmacology|February 27, 2026
Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressantsClotilde Guidetti, George I Papakostas, Steven Stahl, et al.
Pageof 2